Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JULY 02, 2017 FBO #5700
SOURCES SOUGHT

R -- Gliptin Effects in Rodent Model of Parkinson’s Disease - Sources Sought 4574530

Notice Date
6/30/2017
 
Notice Type
Sources Sought
 
NAICS
541690 — Other Scientific and Technical Consulting Services
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211, MSC 9559, Bethesda, Maryland, 20892-9559, United States
 
ZIP Code
20892-9559
 
Solicitation Number
HHS-NIH-NIDA-SSSA-SS-17-485
 
Archive Date
7/22/2017
 
Point of Contact
Danielle R. Brown, Phone: 301 480 2385, Rachelle Trice, Phone: 3015941928
 
E-Mail Address
danielle.brown2@nih.gov, rachelle.trice@nih.gov
(danielle.brown2@nih.gov, rachelle.trice@nih.gov)
 
Small Business Set-Aside
N/A
 
Description
Gliptin Effects in Rodent Model of Parkinson’s Disease Sources Sought 4574530 The purpose of this acquisition is to procure commercial consulting support services to aid in the evaluation of a gliptin drug in a rodent 6-hydroydopamine-induced model of Parkinson's disease. Results from this study will in optimizing our understanding of gliptin drugs as a treatment strategy for Parkinson's disease. Parkinson's disease (PD) is a widespread neurodegenerative disorder that impacts approximately 1.5% of worldwide population over the age of 65 years. Presently available treatment is focused towards dopamine (DA) replacement and, although such therapy can at initially be effective in ameliorating PD associated motor symptoms associated with PD, disease progression invariably occurs and the development of motor fluctuations and dyskinesias ensue that detrimentally impact the quality of life and mobility of PD patients. Consequently, there is a pressing present need to develop new effective treatments for PD. Please see the attached Sources Sought notice for further information. All capability statements are to be sent to the Contract Specialist, Danielle R. Brown, via email at danielle.brown2@nih.gov by Friday, July 7, 2017 at 2PM EST.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/HHS-NIH-NIDA-SSSA-SS-17-485/listing.html)
 
Place of Performance
Address: 251 Bayview Boulevard, Baltimore, Maryland, 21224, United States
Zip Code: 21224
 
Record
SN04565329-W 20170702/170630235204-9e3b48239a6dea99ea1a4c1dc445d8b7 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.